{"id":"W2973068166","doi":"10.1161/circulationaha.119.040167","title":"Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention","year":2019,"lang":"en","type":"review","venue":"Circulation","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":796,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University; 123 Certification (Canada)","funders":"Janssen Pharmaceuticals; National Center for Advancing Translational Sciences; Abbott Vascular; St. Jude Medical; National Institutes of Health; Idorsia Pharmaceuticals; Daiichi Sankyo Europe; Gilead Sciences; Servier; Eisai; Sanofi; Abiomed; Osprey Medical; Chiesi USA; Claret Medical; Biosense Webster; Novo Nordisk; Daiichi-Sankyo; Medicines Company; Cook Medical; Boston Scientific Corporation; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; Abbott Laboratories; CSL Behring; University of Florida; B. Braun Melsungen; Amgen; Pfizer; Medicure","keywords":"Medicine; Percutaneous coronary intervention; Clinical trial; Population; Guideline; Regulatory affairs; Intensive care medicine; Medical emergency; Myocardial infarction; Internal medicine; Environmental health; Pathology; Public administration","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002757273,0.0002876848,0.001148435,0.000296347,0.00006624123,0.00002836759,0.00007243595,0.0003092851,0.00008875618],"category_scores_gemma":[0.0001152456,0.0002736701,0.0009791533,0.0002455015,0.00001935301,0.0001217677,0.00003465508,0.0003592618,0.0001917484],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004310808,"about_ca_system_score_gemma":0.0001316421,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002361277,"about_ca_topic_score_gemma":0.000003197128,"domain_scores_codex":[0.9982423,0.0002233708,0.0005709715,0.0004212174,0.0003250543,0.0002171554],"domain_scores_gemma":[0.9990732,0.0001323127,0.0003539092,0.0003206379,0.00005854632,0.00006138026],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.00004439623,0.00009931953,0.06109117,0.009754096,0.0005161474,0.00005463282,0.00003258359,0.0001208774,9.593644e-8,0.00006863977,0.000007091668,0.928211],"study_design_scores_gemma":[0.01165019,0.0007472305,0.6282678,0.1856657,0.02210251,0.001610174,0.0002077628,0.0007210931,5.502293e-7,0.0003655346,0.1466272,0.002034292],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.05878717,0.939403,0.0001910373,0.000001336565,0.0003883278,0.0009494648,0.00002143449,0.00005831087,0.0001998996],"genre_scores_gemma":[0.3030477,0.6954888,0.0000415967,0.00000865328,0.0000703352,0.00001396947,0.001259517,0.00005133928,0.00001816528],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9261767,"threshold_uncertainty_score":0.9999716,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02278705769970059,"score_gpt":0.2842924585683699,"score_spread":0.2615054008686693,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}